"Glaucoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Descriptor ID |
D005901
|
MeSH Number(s) |
C11.525.381
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glaucoma".
Below are MeSH descriptors whose meaning is more specific than "Glaucoma".
This graph shows the total number of publications written about "Glaucoma" by people in this website by year, and whether "Glaucoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 2 | 1 | 3 |
2003 | 2 | 0 | 2 |
2004 | 3 | 1 | 4 |
2005 | 1 | 1 | 2 |
2007 | 2 | 1 | 3 |
2008 | 1 | 0 | 1 |
2009 | 3 | 0 | 3 |
2010 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2012 | 6 | 1 | 7 |
2013 | 4 | 0 | 4 |
2014 | 3 | 1 | 4 |
2015 | 2 | 1 | 3 |
2016 | 5 | 0 | 5 |
2017 | 6 | 1 | 7 |
2018 | 3 | 0 | 3 |
2019 | 4 | 0 | 4 |
2020 | 5 | 0 | 5 |
2021 | 3 | 0 | 3 |
2022 | 2 | 0 | 2 |
2023 | 9 | 0 | 9 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glaucoma" by people in Profiles.
-
Su E, Mohammadzadeh V, Mohammadi M, Shi L, Law SK, Coleman AL, Caprioli J, Weiss RE, Nouri-Mahdavi K. A Bayesian Hierarchical Spatial Longitudinal Model Improves Estimation of Local Macular Rates of Change in Glaucomatous Eyes. Transl Vis Sci Technol. 2024 01 02; 13(1):26.
-
Ho C, Tseng VL, Grassi L, Morales E, Yu F, Coleman AL, Caprioli J. Predictors of Glaucomatous Progression in Individuals with Small and Large Optic Discs. Ophthalmol Glaucoma. 2024 Mar-Apr; 7(2):177-189.
-
Tseng VL, Kitayama K, Yu F, Coleman AL. Prevalence and Severity of Glaucoma in the California Medicare Population. Am J Ophthalmol. 2024 Mar; 259:25-34.
-
Paul M, Kitayama K, Yu F, Tseng VL, Coleman AL. Access to Eye Care Providers and Glaucoma Severity in the National Institutes of Health All of Us Research Program. J Glaucoma. 2023 12 01; 32(12):1044-1051.
-
Tseng VL, Kitayama K, Yu F, Coleman AL. Disparities in Glaucoma Surgery: A Review of Current Evidence and Future Directions for Improvement. Transl Vis Sci Technol. 2023 09 01; 12(9):2.
-
Yao M, Kitayama K, Yu F, Tseng VL, Coleman AL. Association Between Myopia and Primary Open-Angle Glaucoma by Race and Ethnicity in Older Adults in the California Medicare Population. JAMA Ophthalmol. 2023 06 01; 141(6):525-532.
-
Tseng VL, Kitayama K, Yu F, Pan D, Coleman AL. Social Vulnerability, Prevalence of Glaucoma, and Incidence of Glaucoma Surgery in the California Medicare Population. Ophthalmol Glaucoma. 2023 Nov-Dec; 6(6):616-625.
-
Lee SY, Tseng VL, Kitayama K, Avallone TJ, Yu F, Pan D, Caprioli J, Coleman AL. Associations Between Niacin Intake and Glaucoma in the National Health and Nutrition Examination Survey. J Glaucoma. 2023 06 01; 32(6):443-450.
-
Paul ME, Tseng VL, Kitayama K, Yu F, Coleman AL. Evaluating Discrepancies in Self-Reported Glaucoma and Electronic Health Records in the National Institutes of Health All of Us Database. Ophthalmol Glaucoma. 2023 Sep-Oct; 6(5):521-529.
-
Mohammadzadeh V, Su E, Mohammadi M, Law SK, Coleman AL, Caprioli J, Weiss RE, Nouri-Mahdavi K. Association of Blood Pressure With Rates of Macular Ganglion Cell Complex Thinning in Patients With Glaucoma. JAMA Ophthalmol. 2023 03 01; 141(3):251-257.